Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Terns Pharmaceuticals (TERN) over the last 5 years, with Dec 2024 value amounting to $84.9 million.

  • Terns Pharmaceuticals' Shares Outstanding (Weighted Average) rose 64.29% to $61.8 million in Q4 2023 from the same period last year, while for Sep 2023 it was $61.1 million, marking a year-over-year increase of 140.78%. This contributed to the annual value of $84.9 million for FY2024, which is 37.45% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Shares Outstanding (Weighted Average) stood at $84.9 million for FY2024, which was up 37.45% from $61.8 million recorded in FY2023.
  • Over the past 5 years, Terns Pharmaceuticals' Shares Outstanding (Weighted Average) peaked at $84.9 million during FY2024, and registered a low of $25.1 million during FY2020.
  • In the last 3 years, Terns Pharmaceuticals' Shares Outstanding (Weighted Average) had a median value of $61.8 million in 2023 and averaged $61.4 million.
  • Data for Terns Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY surged of 64.29% (in 2023) over the last 5 years.
  • Over the past 5 years, Terns Pharmaceuticals' Shares Outstanding (Weighted Average) (Yearly) stood at $25.1 million in 2020, then increased by 0.57% to $25.3 million in 2021, then surged by 48.86% to $37.6 million in 2022, then skyrocketed by 64.29% to $61.8 million in 2023, then surged by 37.45% to $84.9 million in 2024.